Processa Pharmaceuticals, Inc. · NASDAQ:PCSA

Ng George K exercised options for 1,600 Processa Pharmaceuticals, Inc. shares (Form 4)

Traded Aug 8, 2026 · Filed Aug 11, 2026

On Aug 8, 2026, Ng George K (Director, Chief Executive Officer) exercised options for 1,600 Processa Pharmaceuticals, Inc. shares, leaving 17,092 shares. Filed Aug 11, 2026 (Form 4).

Options exercised
1,600 shares
Holding after
17,092 shares
Trading plan
No
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 8, 2026Common StockOption exercise1,60017,092Direct

Source

View original at SEC

Related